Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › NVCT
SPHERA FUNDS MANAGEMENT LTD. position in NVCT
NUVECTIS PHARMA INC · Health Care
SPHERA FUNDS MANAGEMENT LTD. reported holding 323,425 shares of NVCT (NUVECTIS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 1.05% of its reported portfolio and ranking #34 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed NVCT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How SPHERA FUNDS MANAGEMENT LTD.'s NVCT position evolved
SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in NVCT in Q2 2026 at 382,945 shares (US$7.0M). Across 2 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 323,425 shares valued at US$6.8M — a reduction of -59,520 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 382.94K | $7.04M | New |
| Q3 2026 | 323.43K | $6.83M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVCT and 13F data
NVCT (NUVECTIS PHARMA INC) is a Health Care company. 62 other funds we track also report a position in NVCT — the largest reported positions include Soleus Capital Management, L.P. (US$36.1M), TANG CAPITAL MANAGEMENT LLC (US$33.3M), BRAIDWELL LP (US$33.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVCT
- Soleus Capital Management, L.P. 1.71M sh · $36.13M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.58M sh · $33.33M · Q3 2026
- BRAIDWELL LP 1.57M sh · $33.24M · Q3 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 793.21K sh · $16.75M · Q3 2026
- Parkman Healthcare Partners LLC 425.35K sh · $8.98M · Q3 2026
- BALDWIN WEALTH PARTNERS LLC/MA 382.01K sh · $8.07M · Q3 2026
- Occam Crest Management LP 2.80K sh · $3.09M · Q3 2026
- Avidity Partners Management LP 100.42K sh · $2.12M · Q3 2026
More on SPHERA FUNDS MANAGEMENT LTD.
FAQ
How long has SPHERA FUNDS MANAGEMENT LTD. held NVCT?
SPHERA FUNDS MANAGEMENT LTD. has disclosed NVCT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is SPHERA FUNDS MANAGEMENT LTD.'s current position in NVCT?
As of Q3 2026, SPHERA FUNDS MANAGEMENT LTD. holds 323.43K shares of NVCT (NUVECTIS PHARMA INC), valued at $6.83M, representing 1.05% of its reported portfolio and ranking #34.
Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling NVCT?
In the latest 13F filing (Q3 2026), SPHERA FUNDS MANAGEMENT LTD. reduced its position in NVCT.
Which other funds hold NVCT?
Other major institutional holders of NVCT include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, BRAIDWELL LP, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.